5 Trends Defining Healthcare’s Generative AI Strategy

Rather than debating whether to engage with AI, most providers are now focused on where it can be applied first and how soon it can deliver value.

2. Early use cases are focused on productivity

Though the first wave of generative AI deployment has been concentrated on administrative tasks, hospitals and health systems are expanding implementation use cases.

Among clinical-care organizations surveyed, clinical productivity led the way for adoption areas at 54%, followed by administration efficiency at 38%.

Organizations are beginning to move beyond back-office applications and growing more comfortable with deploying generative AI closer to the point of care, even if it’s within the parameters of enhancing clinical decision-making.

3. Most organizations are partnering, not building

While adoption is widespread, relatively few organizations are developing generative AI tools internally.

According to the survey, 45% of clinical-care respondents are partnering with third-party vendors and 36% are considering off-the-shelf solutions, compared to just 19% pursuing in-house development.

This approach reflects hospitals’ limited internal technical expertise, the speed of innovation in the vendor ecosystem, and the complexity of building and maintaining generative AI systems at scale. As a result, many providers are outsourcing a significant portion of their AI capability stack to achieve faster deployment and immediate returns.

4. Confidence in ROI is rising

Among respondents that have implemented generative AI, roughly 82% expect a positive return on investment, with 45% reporting quantified returns. Those figures suggest growing confidence in the technology’s potential to improve efficiency and reduce costs.

However, many organizations are still in the process of defining how to measure that value consistently. ROI frameworks are evolving, and in many cases, benefits are being tracked in fragmented or early-stage ways rather than through standardized metrics.

5. Workflow disruption is the biggest barrier

Despite strong momentum, longstanding concerns around risk, regulation, and governance continue to drive hesitation in how generative AI is deployed. But the most immediate challenge is operational, with 59% of respondents citing difficulty integrating or adapting tools to existing workflows as their top concern.

If implemented solutions create more friction in workflows, clinical staff are unlikely to keep using it, making it vital that providers work with physicians and nurses to develop and test tools before committing.

Within risk concerns, cited by 43% of respondents, the biggest worries were inaccuracies/biases/flaws in generative AI solutions models (66%), security risks (60%), and regulatory compliance (52%).

These barriers aren’t slowing adoption outright, but instead influencing where and how AI is being used, steering organizations toward more controlled deployment.